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Contribution of 
perinatal conditions to 
cerebral palsy in Uganda
Worldwide, an estimated 93 million 
children are disabled, 80% of whom 
live in low-income countries.1 Cohort 
studies in high-income countries 
attribute more than 50% of cerebral 
palsy cases to premature birth or 
prenatal causes.2 Equivalent data have 
been difficult to obtain in low-resource 
settings, limiting the ability to lobby 
for better service provision for these 
children.
In October, 2017, Angelina Kakooza-
Mwesige and colleagues3 published 
the largest population-based study of 
cerebral palsy in sub-Saharan Africa. 
This important work highlighted the 
higher prevalence of cerebral palsy in 
children in sub-Saharan Africa than 
in children in high-income countries, 
and that a greater proportion of cases 
are from potentially preventable 
causes. However, for diagnostic 
precision, consistent with all major 
international cerebral palsy registers, 
children younger than 2 years were 
not included. We suggest that further 
exploration of this younger group is 
important given the high proportion 
of full-term neonatal cases with severe 
cerebral palsy identified in this setting.
We wish to add our experience of 
this important younger subgroup 
in an urban hospital setting in 
Kampala, Uganda. We investigated 
the causes and subtypes of cerebral 
palsy in 130 children younger than 
18 years who presented to Mulago 
National Referral Hospital—the largest 
paediatric centre in Uganda—over 
an 8 week period in 2013. Children 
younger than 2 years were not 
excluded because of concern that 
those with severe cerebral palsy might 
not survive beyond early childhood. 
Children in whom there was concern 
about movement or posture were 
identified by doctors and therapists 
working in the paediatric in-patient 
wards and neurology, physiotherapy, 
and occupational therapy clinics. 
Children were recruited and assessed 
by the study lead (JH) or a local 
paediatrician trained in cerebral palsy 
assessment, assisted by a local 
language (Luganda) translator. Written 
consent was obtained. Cerebral palsy 
diagnosis was confirmed in cases of 
onset of non-progressive movement 
disorder before age 2 years. Children 
with neural tube defects or isolated 
hypotonia were excluded.
Assessment involved obtaining 
detailed retrospective histories from 
primary caregivers, including any 
self-identified antecedents to the 
onset of motor impairment, and 
neurological examination. Cerebral 
palsy subtype was assigned according 
to the Surveillance of Cerebral Palsy 
in Europe hierarchical classification. 
Neuroimaging was not available.
In this hospital-based cohort, 
56% of patients were male, 9% were 
in-patients, and 63% were younger 
than 2 years (median age 17 months 
[IQR 9–29]). 78% of patients had 
bilateral spastic disease; 72% had 
four-limb spastic disease resulting 
in severe functional impairment. 
68% of caregivers gave histories 
consistent with term intrapartum-
related encephalopathy or neonatal 
sepsis, and 76% attributed their child’s 
cerebral palsy to severe (full-term) 
neonatal illness, supported by a history 
of admission to neonatal care facilities 
(table). Two children were HIV positive.
Key differences exist between our 
urban hospital-based cohort and the 
predominantly rural population-based 
cohort reported by Kakooza-Mwesige 
and colleagues.3 Our cohort was 
younger (median age 17 months vs 
4–5 years), with more cases of four-
limb cerebral palsy, suggesting a 
higher prevalence of global brain injury 
that usually results from intrapartum 
or neonatal complications, as opposed 
to less disabling unilateral lesions.
The younger age of patients and 
greater severity of disease seen in 
our hospital cohort might reflect 
increased care seeking or referral for 
these patients, as well as an increased 
incidence of comorbidities (eg, 
infection, malnutrition) precipitating 
Total (n=130) Subtype of cerebral palsy
Bilateral spastic (n=101) Unilateral spastic (n=15) Dyskinetic (n=14)
Premature birth (<37 weeks) 8 (6%) 8/8 (100%) 0/8 (0%) 0/8 (0%)
Term neonatal illness 99 (76%) ·· ·· ··
Intrapartum-related encephalopathy, with or without infection 75 (58%) 66/75 (88%) 5/75 (7%) 4/75 (5%)
Neonatal sepsis, with no evidence of encephalopathy 14 (11%) 13/14 (93%) 1/14 (7%) 0/14 (0%)
Neonatal jaundice 7 (5%) 0/7 (0%) 0/7 (0%) 7/7 (100%)
Other neonatal illness 3 (2%) 1/3 (33%) 2/3 (67%) 0/3 (0%)
Post-neonatal event 14 (11%) ·· ·· ··
CNS infection 12 (9%) 9/12 (75%) 2/12 (17%) 1/12 (8%)
Other 2 (2%) 0/2 (0%) 2/2 (100%) 0/2 (0%)
Unknown 9 (7%) 4/9 (44%) 3/9 (33%) 2/9 (22%)
Data are n (%) or n/N (%).
Table: Attributed causes of cerebral palsy
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neurodevelopmental outcomes in 
survivors.6,7,8 Together, these studies 
emphasise the substantial burden of 
severe neurodisability attributable to 
term neonatal morbidity. Intrapartum 
and newborn care must remain key 
priorities to ensure all children can 
survive and thrive.
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hospital attendance. In another 
Mulago Hospital-based study of 
cerebral palsy, also by Kakooza-
Mwesige and colleagues,4 children 
older than 2 years recruited from 
the cerebral palsy outpatient service 
(n=135) were also younger (median 
age 3·5 years) and more had severe 
impairment (39% vs 20%) than in the 
recent population-based study.3
Difficulty confirming cerebral 
palsy subtype in children younger 
than 2 years might have affected our 
findings; neurodisability from severe 
brain injury is often apparent early, 
whereas milder impairments might 
be missed. The lower proportion 
of bilateral spastic disease in 
Kakooza-Mwesige and colleagues’ 
hospital-based cohort4 than in our 
cohort (46% vs 78%) might be 
explained by our inclusion of patients 
younger than 2 years and of in-
patients, potentially with cerebral 
palsy-related comorbidities. However, 
the population-based study3 also 
showed a trend towards increased 
cerebral palsy prevalence and severity 
in younger children. The very high 
proportion of severely disabled young 
children in our hospital-based cohort 
indicates an increased early morbidity 
and mortality. Therefore, studies 
excluding young children might 
underestimate the preventable burden 
of severe neurodisability.
Importantly, 73% of Kakooza-
Mwesige and colleagues’ population-
based cohort3 were neonatal 
full-term cases; however, no further 
perinatal history was given. Our 
study suggests that intrapartum-
related encephalopathy and sepsis 
are key contributors to this cerebral 
palsy burden and that severe cases 
attributed to these causes might die 
before reaching age 2 years, when 
they can be included in cerebral palsy 
registries.
Newborn deaths due to premature 
birth, intrapartum-related events, 
and sepsis account for almost half of 
under-5 mortality worldwide,5 with 
a high estimated burden of adverse 
